US 11161908
BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof
granted A61KA61K2039/505A61K2239/31
Quick answer
US patent 11161908 (BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2039/505, A61K2239/31, A61K2239/38, A61K2239/48